IS8315A - Breytt IL-4 mútein viðtaka mótlyf - Google Patents

Breytt IL-4 mútein viðtaka mótlyf

Info

Publication number
IS8315A
IS8315A IS8315A IS8315A IS8315A IS 8315 A IS8315 A IS 8315A IS 8315 A IS8315 A IS 8315A IS 8315 A IS8315 A IS 8315A IS 8315 A IS8315 A IS 8315A
Authority
IS
Iceland
Prior art keywords
modified
receptor antagonists
mutant receptor
mutant
antagonists
Prior art date
Application number
IS8315A
Other languages
English (en)
Inventor
Pan Clark
Roczniak Steve
Michael Greve Jeffrey
L. Yung Stephanie
Longphre Malinda
Mo-Fun Wong Teresa
Tomkinson Adrian
Original Assignee
Bayer Pharmaceuticals Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corporation filed Critical Bayer Pharmaceuticals Corporation
Publication of IS8315A publication Critical patent/IS8315A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/45—Toxoplasma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Cell Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IS8315A 2003-08-29 2006-02-20 Breytt IL-4 mútein viðtaka mótlyf IS8315A (is)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US49890603P 2003-08-29 2003-08-29
US52822803P 2003-12-09 2003-12-09
US53018203P 2003-12-17 2003-12-17
US10/820,559 US7404957B2 (en) 2003-08-29 2004-04-08 Modified IL-4 mutein receptor antagonists
PCT/US2004/023310 WO2005023860A2 (en) 2003-08-29 2004-07-20 Modified il-4 mutein receptor antagonists

Publications (1)

Publication Number Publication Date
IS8315A true IS8315A (is) 2006-02-20

Family

ID=34280052

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8315A IS8315A (is) 2003-08-29 2006-02-20 Breytt IL-4 mútein viðtaka mótlyf

Country Status (15)

Country Link
US (1) US7404957B2 (is)
EP (1) EP1660529A2 (is)
JP (1) JP4774368B2 (is)
KR (1) KR20070008505A (is)
AU (1) AU2004270638B2 (is)
BR (1) BRPI0413869A (is)
CA (1) CA2536586A1 (is)
CZ (1) CZ2006206A3 (is)
DK (1) DK200600449A (is)
ES (1) ES2315146A1 (is)
FI (1) FI20060188A7 (is)
IL (1) IL173746A0 (is)
IS (1) IS8315A (is)
MX (1) MXPA06002285A (is)
WO (1) WO2005023860A2 (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785580B2 (en) * 2003-08-29 2010-08-31 Aerovance, Inc. Modified IL-4 mutein receptor antagonists
AU2005282065B2 (en) * 2004-09-10 2013-02-07 Pharmaorigin Aps Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis
US20070009479A1 (en) * 2005-06-17 2007-01-11 Aerovance, Inc. Methods for treating dermatitis using mutant human IL-4 compositions
WO2007019232A2 (en) * 2005-08-03 2007-02-15 Immunogen, Inc. Immunoconjugate formulations
CA2635996A1 (en) * 2006-01-11 2007-07-19 Aerovance, Inc. Methods and compositions for treating asthma in human and non human primates
AU2007271349A1 (en) * 2006-07-06 2008-01-10 Apogenix Gmbh Human IL-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy
CN101784280A (zh) * 2007-07-11 2010-07-21 艾罗文斯公司 药物多肽干粉气溶胶制剂及制备方法
US20110034678A1 (en) * 2009-03-13 2011-02-10 Aerovance, Inc. Methods of renaturation of recombinant proteins
AU2011263786B2 (en) 2010-06-08 2014-11-13 Astrazeneca Ab Tear lipocalin muteins binding IL-4 R alpha
WO2015000585A1 (en) 2013-07-02 2015-01-08 Walter Sebald Muteins of cytokines of the gamma-chain receptor family conjugated to a non-protein group
WO2019148405A1 (zh) * 2018-02-01 2019-08-08 北京凯因科技股份有限公司 IL-4Rα抗体及其用途
EP3553078A1 (en) * 2018-04-11 2019-10-16 Julius-Maximilians-Universität Würzburg Glyco-engineered interleukin-4 based antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4423131A1 (de) * 1994-07-01 1996-01-04 Bayer Ag Neue hIL-4-Mutantenproteine als Antagonisten oder partielle Agonisten des humanen Interleukin 4
GB9415379D0 (en) * 1994-07-29 1994-09-21 Smithkline Beecham Plc Novel compounds
US5986059A (en) 1996-06-14 1999-11-16 Bayer Corporation T-cell selective interleukin-4 agonists
MY124565A (en) 1996-07-19 2006-06-30 Bayer Corp High-affinity interleukin-4-muteins
US6028176A (en) 1996-07-19 2000-02-22 Bayer Corporation High-affinity interleukin-4 muteins
CN1269805A (zh) * 1997-07-14 2000-10-11 博尔德生物技术公司 生长激素和相关蛋白的衍生物
US9303613B2 (en) 2012-02-24 2016-04-05 Ford Global Technologies, Llc Control of vehicle electrical loads during engine auto stop event

Also Published As

Publication number Publication date
JP2007526757A (ja) 2007-09-20
WO2005023860A3 (en) 2005-06-23
CZ2006206A3 (cs) 2007-01-10
IL173746A0 (en) 2006-07-05
CA2536586A1 (en) 2005-03-17
BRPI0413869A (pt) 2006-10-24
WO2005023860A2 (en) 2005-03-17
US7404957B2 (en) 2008-07-29
DK200600449A (da) 2006-03-29
AU2004270638B2 (en) 2010-10-07
AU2004270638A2 (en) 2005-03-17
JP4774368B2 (ja) 2011-09-14
ES2315146A1 (es) 2009-03-16
FI20060188L (fi) 2006-02-24
AU2004270638A1 (en) 2005-03-17
MXPA06002285A (es) 2007-03-15
EP1660529A2 (en) 2006-05-31
US20050059590A1 (en) 2005-03-17
FI20060188A7 (fi) 2006-04-28
KR20070008505A (ko) 2007-01-17

Similar Documents

Publication Publication Date Title
DE602004030930D1 (de) Muscarinische acetylcholin-rezeptor-antagonisten
DK1682142T3 (da) M3-muscarin-acetylcholin-receptor-antagonister
ATE413400T1 (de) Cgrp-rezeptorantagonisten
DE60321740D1 (de) Toner
DE60306080D1 (de) Toner
ATE450505T1 (de) Cb 1 rezeptor inversagonisten
DK1743027T3 (da) Mutantpneumolysinproteiner
NO20050429D0 (no) Substituert kinolin-CCR5-reseptorantagonister
DK1472256T3 (da) Piperidinderivater
DE60328378D1 (de) Toner
ATE382034T1 (de) Hydroisoindolin-tachykininrezeptorantagonisten
ATE432282T1 (de) 2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4- triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten
ATE469875T1 (de) Nk1-antagonisten
FI20060188L (fi) Modifioidut IL-4-muteiinin reseptorin antagonistit
DE60324018D1 (de) Agonisten
DE602004023664D1 (de) Toner
DE60321615D1 (de) Toner
NO20043799L (no) 2-oksasolaminer og deres anvendelse som 5-HT2B reseptor antagonister
ATA2792002A (de) Temperaturfühler
DE60328807D1 (de) Chimärer antagonist anth1
FR2841758B1 (fr) Oreiller ostheopatique
DE10392685D2 (de) Sitzmöbel
FI20021353A0 (fi) Istuin
TH105710B (th) โอพิออยด์รีเซปเตอร์แอนตะกอนิสต์
EE00339U1 (et) Istumisseade